Filing Details

Accession Number:
0001179110-22-000398
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-11 16:18:52
Reporting Period:
2022-01-07
Accepted Time:
2022-01-11 16:18:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1778279 Luisa Emily Hill C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-01-07 800 $38.53 22,333 No 4 S Direct
Common Stock Acquisiton 2022-01-07 15,600 $0.00 37,933 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2022-01-07 58,500 $0.00 58,500 $38.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
58,500 2032-01-06 No 4 A Direct
Footnotes
  1. Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,700 RSUs from a January 6, 2021 grant of 10,800 RSUs.
  2. Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
  3. This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.